The Centers for Medicare and Medicaid Services said Tuesday it seeks to lower Medicare costs for 16 medications by negotiating with their manufacturers. Among them is Biktarvy, a drug taken after HIV ...
The National Alliance of State and Territorial AIDS Directors estimates 16,000 will lose assistance for the drugs or premiums.
HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but ...
The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead ...
The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...
The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...
The debate over Florida’s HIV medication cuts is intensifying as advocates, lawmakers, and healthcare professionals push back ...
Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
In South Africa, a gay man put his life on the line to draw attention to AIDS suffering. In India, a scientist stood up to ...
The complaint claims that the state illegally changed rules regarding income eligibility thresholds for the AIDS Drug ...
State health officials pointed to lack of additional funding and rising healthcare insurance premiums nationwide.
Advocates warn the cuts to Florida’s AIDS Drug Assistance Program may increase health risks statewide and reduce access for thousands.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results